semaglutide gout GLP-1 weight loss drug study finds small increase in risk of osteoporosis and Weight loss with semaglutide reduces

Setmelanotide is also known as Synonym

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

It also raises the risk of sarcopenia the age-related loss of muscle mass and function that contributes to frailty, falls, and reduced quality of life

Learn what NICE guidelines advise and how to discuss options with your GP.

GLP-1 injections are typically administered once weekly for weight management, with doses escalated gradually over 16-20 weeks

Most patients notice appetite suppression within 37 days of starting GLP-1 therapy, with measurable weight changes appearing by week 24